IL145582A0 - Monthly doses for treatment of streptococcus pneumoniae infections - Google Patents

Monthly doses for treatment of streptococcus pneumoniae infections

Info

Publication number
IL145582A0
IL145582A0 IL14558200A IL14558200A IL145582A0 IL 145582 A0 IL145582 A0 IL 145582A0 IL 14558200 A IL14558200 A IL 14558200A IL 14558200 A IL14558200 A IL 14558200A IL 145582 A0 IL145582 A0 IL 145582A0
Authority
IL
Israel
Prior art keywords
treatment
streptococcus pneumoniae
pneumoniae infections
monthly doses
monthly
Prior art date
Application number
IL14558200A
Other languages
English (en)
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of IL145582A0 publication Critical patent/IL145582A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/14—Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pulmonology (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Otolaryngology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IL14558200A 1999-05-03 2000-04-19 Monthly doses for treatment of streptococcus pneumoniae infections IL145582A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13225899P 1999-05-03 1999-05-03
PCT/US2000/008737 WO2000066144A2 (en) 1999-05-03 2000-04-19 Monthly doses of glycopeptide antibiotics for treatment of streptococcus pneumoniae infections

Publications (1)

Publication Number Publication Date
IL145582A0 true IL145582A0 (en) 2002-06-30

Family

ID=22453188

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14558200A IL145582A0 (en) 1999-05-03 2000-04-19 Monthly doses for treatment of streptococcus pneumoniae infections
IL145582A IL145582A (en) 1999-05-03 2001-09-24 Use of NDISACC (4- (4-chlorophenyl) -benzyl) B82846A or tycoplanin, in the preparation of long-term treatment drugs for the prevention of streptococcal pneumoniae infections

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL145582A IL145582A (en) 1999-05-03 2001-09-24 Use of NDISACC (4- (4-chlorophenyl) -benzyl) B82846A or tycoplanin, in the preparation of long-term treatment drugs for the prevention of streptococcal pneumoniae infections

Country Status (29)

Country Link
EP (1) EP1175222B1 (xx)
JP (1) JP2002543146A (xx)
KR (1) KR100757165B1 (xx)
CN (1) CN1349407A (xx)
AR (1) AR023827A1 (xx)
AT (1) ATE284702T1 (xx)
AU (1) AU774647B2 (xx)
BR (1) BR0010244A (xx)
CA (1) CA2372790A1 (xx)
CZ (1) CZ296127B6 (xx)
DE (1) DE60016734T2 (xx)
DZ (1) DZ3039A1 (xx)
EA (1) EA004295B1 (xx)
HK (1) HK1044707B (xx)
HR (1) HRP20010808A2 (xx)
HU (1) HUP0200940A3 (xx)
IL (2) IL145582A0 (xx)
MY (1) MY123542A (xx)
NO (1) NO20015291L (xx)
NZ (1) NZ514467A (xx)
PE (1) PE20010292A1 (xx)
PL (1) PL353444A1 (xx)
SK (1) SK285970B6 (xx)
SV (1) SV2002000065A (xx)
TR (1) TR200103211T2 (xx)
TW (1) TWI255716B (xx)
UA (1) UA73937C2 (xx)
WO (1) WO2000066144A2 (xx)
ZA (1) ZA200108013B (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2013202360B2 (en) * 2008-08-30 2016-03-24 Melinta Therapeutics, Inc. Methods of treatment using single doses of oritavancin
CN102215858A (zh) * 2008-08-30 2011-10-12 塔尔甘塔治疗公司 使用单剂量奥利万星的治疗方法
US20160206688A1 (en) * 2013-08-26 2016-07-21 The Medicines Company Methods for treating bacteremia and osteomyelitis using oritavancin

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5840684A (en) * 1994-01-28 1998-11-24 Eli Lilly And Company Glycopeptide antibiotic derivatives

Also Published As

Publication number Publication date
NZ514467A (en) 2005-01-28
CZ20013949A3 (cs) 2002-07-17
TR200103211T2 (tr) 2002-02-21
CA2372790A1 (en) 2000-11-09
CN1349407A (zh) 2002-05-15
PL353444A1 (en) 2003-11-17
DE60016734D1 (de) 2005-01-20
KR100757165B1 (ko) 2007-09-07
IL145582A (en) 2008-12-29
BR0010244A (pt) 2002-01-08
SK285970B6 (sk) 2007-12-06
WO2000066144A3 (en) 2001-04-12
HK1044707A1 (en) 2002-11-01
TWI255716B (en) 2006-06-01
NO20015291D0 (no) 2001-10-29
HRP20010808A2 (en) 2002-12-31
EA200101171A1 (ru) 2002-04-25
KR20020008173A (ko) 2002-01-29
AU774647B2 (en) 2004-07-01
ATE284702T1 (de) 2005-01-15
SK15572001A3 (sk) 2003-05-02
HUP0200940A2 (en) 2002-08-28
AR023827A1 (es) 2002-09-04
DZ3039A1 (fr) 2004-03-27
EP1175222B1 (en) 2004-12-15
NO20015291L (no) 2001-12-17
SV2002000065A (es) 2002-12-02
HK1044707B (zh) 2005-09-30
EA004295B1 (ru) 2004-02-26
HUP0200940A3 (en) 2002-10-28
WO2000066144A2 (en) 2000-11-09
EP1175222A2 (en) 2002-01-30
MY123542A (en) 2006-05-31
DE60016734T2 (de) 2005-12-08
ZA200108013B (en) 2003-03-26
PE20010292A1 (es) 2001-03-07
AU4329200A (en) 2000-11-17
UA73937C2 (en) 2005-10-17
CZ296127B6 (cs) 2006-01-11
JP2002543146A (ja) 2002-12-17

Similar Documents

Publication Publication Date Title
IL148641A0 (en) Topical treatment of streptococcal infections
HUS1500040I1 (hu) Sztreptokokkusz oltóanyag
EP1162994A4 (en) COMPOSITION FOR THE PROPHYLACTIC AND THERAPEUTIC TREATMENT OF STREPTOCOCCAL INFECTIONS
HK1022439A1 (en) Pharmaceutical compositions containing lactobacilli for treatment fo vaginal infections
AU4832000A (en) Methods for quantitating the efficacy of oral care products
IL151890A0 (en) Hydroxyphenyl-piperidin 4-ylidene-methyl-benzamide derivatives for the treatment of pain
ZA200108215B (en) Compositions and methods for treatment of staphylococcal infection.
AU2000258650A1 (en) 2-piperidone compounds for the treatment of cancer
IL151891A0 (en) Quinolinyl-piperidin 4-ylidene-methyl-benzamide derivatives for the treatment of pain
IL151765A0 (en) Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain
IL133760A0 (en) Composition for the treatment of dandruff
IL145582A0 (en) Monthly doses for treatment of streptococcus pneumoniae infections
DE60023158D1 (en) Phagenresistentes streptococcus thermophilus
HUP0105310A3 (en) Use of phosphororganic compounds for the prophylactic and therapeutical treatment of infections
AU1646701A (en) Composition for treating respiratory tract infections
AU4145999A (en) Topical drug for the treatment of viral infections
AU5493500A (en) Antibody-based treatment for streptococcus pneumoniae infection
GB9928678D0 (en) Streptococcus pneumoniae antigens
AU2002336752A8 (en) Composition for treating streptococcus pneumoniae
NO991827D0 (no) FremgangsmÕte for behandling av Streptococcus pneumoniae infeksjon
GB2362827B (en) Pharmaceutical preparation for treating viral infections
AU1673200A (en) Medicaments for the treatment of lung infections
IL136687A0 (en) Pharmaceutical composition for the treatment of multiple sclerosis
PL352876A1 (en) A means for the prophylactic and therapeutic treatment of streptococcal infections
AU139360S (en) Adjustable gate set